Cargando…

P06-09. Web based interviewing system for HIV-behavior research in the settings of vaccine and non vaccine prevention trials

Detalles Bibliográficos
Autores principales:	Peinado, JE, Sanchez, JL, Lama, JR
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768004/ http://dx.doi.org/10.1186/1742-4690-6-S3-P98

Ejemplares similares

P06-06. Capacity building for HIV vaccine trials in Africa through South-South collaboration
por: Mpendo, J, et al.
Publicado: (2009)

P09-06 Getting a grip on sitting behaviour
por: Duijvestijn, Marjolein, et al.
Publicado: (2022)

P14-09. Use of HIV rapid tests for assessment of persistence of vaccine induced antibodies among HIV vaccine recipients
por: Karita, E, et al.
Publicado: (2009)

P18-06. Increased HIV-specific immunity in HIV-infected individuals vaccinated with a DNA prime, rAd5 boost regimen
por: Casazza, JP, et al.
Publicado: (2009)

P09-06. HIV-1 escape from broadly neutralizing anti-CD4 binding site NAbs during HIV-1 infection
por: Sather, D, et al.
Publicado: (2009)

P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine
por: Liu, J, et al.
Publicado: (2009)

P06-08. Building an African HIV preventive trial network
por: Price, MA, et al.
Publicado: (2009)

P15-09. The potential global market size and public health value of hypothetical HIV-1 preventive vaccines with different levels of efficacy
por: Marzetta, CA, et al.
Publicado: (2009)

P06-09 Data processing with the short questionnaire to assess health enhancing physical activity (SQUASH): an update
por: Duijvestijn, Marjolein, et al.
Publicado: (2022)

P15-06. Brighton collaboration viral vector vaccines safety working group (V3SWG): maximizing the comparability and value of safety data from HIV vaccine trials
por: Chen, RT, et al.
Publicado: (2009)

P18-09. Persistent virological benefit in SIV-infected macaques upon therapeutic vaccination upon vaccination with DNA vectors
por: Felber, BK, et al.
Publicado: (2009)

P06-01. Developing a sponsor-initiated clinical guidance for AIDS vaccine research
por: Priddy, F, et al.
Publicado: (2009)

P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape
por: Rong, R, et al.
Publicado: (2009)

OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial
por: Rolland, M, et al.
Publicado: (2009)

P20-06. Study of viral variability evolution in patients submitted to a therapeutic vaccine based on autologous dendritic cells pulsed with autologous HIV-1
por: Guilà, M, et al.
Publicado: (2009)

P06-04. Using referrals from government health centers to expand an HIV discordant couple cohort in Lusaka, Zambia in preparation for vaccine efficacy trials
por: Sitrin, D, et al.
Publicado: (2009)

AAC - LEAR transfer efficiencies from 10/06/96 to 29/09/96
por: Sanchez Alvarez, J.L.
Publicado: (1996)

P16-09. Adenovirus 5 vector HIV vaccination does not affect mucosal homing markers on Ad5-specific CD4+ T-cells in humans
por: Hutnick, N, et al.
Publicado: (2009)

P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine
por: Lewis, DJ, et al.
Publicado: (2009)

T.06.3 DOES SARS-COV-2 VACCINATION AFFECT THE COURSE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS ON BIOLOGICAL THERAPY?
por: De Blasio, F., et al.
Publicado: (2022)

P09-05. Mechanism of HIV-1 resistance to a monoclonal antibody that effectively targets the site of CD4 attachment
por: Wu, X, et al.
Publicado: (2009)

P13-06. DARPin-based microbicide strategies to block HIV entry
por: Mann, A, et al.
Publicado: (2009)

P09-09. Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
por: Wright, JK, et al.
Publicado: (2009)

P09-09 Hybrid work and temporal patterns of sedentary behavior in a 24-hour compositional perspective
por: Hallman, David, et al.
Publicado: (2022)

P06-15 What makes physical activity interventions work in Ireland: findings from interviews with those involved with intervention implementation
por: Murphy, Joey
Publicado: (2022)

P07-06. HIV-1 transmission and early evolution: whole genome analysis
por: Herbeck, JT, et al.
Publicado: (2009)

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial
por: Fellay, J, et al.
Publicado: (2009)

P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope
por: Zolla-Pazner, S, et al.
Publicado: (2009)

P06-05. Building capacity for HIV/AIDS prevention trials in Africa: Evidence from three projects supported by the Global Health Research Initiative
por: Geneau, R, et al.
Publicado: (2009)

P02-09. Dissecting the interference of endotoxins with HIV infection of primary CD4 T cell
por: Krarup, A, et al.
Publicado: (2009)

P09-10. Impact of CTL escape mutations in HIV-1 Nef on viral replication
por: Oniangue-Ndza, C, et al.
Publicado: (2009)

P15-11. Preventive HIV vaccine acceptability: a systematic review and meta-analysis
por: Newman, PA, et al.
Publicado: (2009)

P16-06. Control of HIV-1 by HIV-1 Pol-specific CD8+ T cells in chronically HIV-1-infected Japanese cohort
por: Murakoshi, H, et al.
Publicado: (2009)

Potency of an HIV-SAM™ vaccine in a heterologous prime-boost vaccination regimen
por: Banerjee, K, et al.
Publicado: (2012)

P09-03 Costing the economic burden of sedentary behaviors in France
por: Racine, Antoine Noël, et al.
Publicado: (2022)

P09-17. Evolution of HLA-B*5703 HIV-1 escape mutations and their impact on HIV-1 replicative capacity
por: Crawford, H, et al.
Publicado: (2009)

Peripheral T follicular helper cells from H1N1/09 vaccine nonresponders fail to induce antigen-specific antibody production in vitro
por: Parmigiani, A, et al.
Publicado: (2012)

P19-09. Site-specific incorporation of an unnatural amino acid into the HIV-1 Env spike
por: Arnett, SO, et al.
Publicado: (2009)

New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
por: Penezina, O, et al.
Publicado: (2012)

P19-05. Use of autologous apoptotic pseudovirus infected cells for vaccination against HIV, evaluation in macaques
por: Koopman, G, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9mc64108o4mhdbsd3mnra10fue